Literature DB >> 17518600

Transplantation of preserved human amniotic membrane for bladder augmentation in rats.

Kazuyoshi Iijima1, Yasuhiko Igawa, Tetsuya Imamura, Tetsuzi Moriizumi, Toshio Nikaido, Ikuo Konishi, Osamu Nishizawa.   

Abstract

Although gastrointestinal segments have been widely used for bladder reconstruction, they are not ideal because of the possible complications. Searches have therefore continued for an alternative material for augmentation. Here, we performed bladder augmentation in rats using human amniotic membrane (hAM). Morphologically, the hAM-augmented bladder revealed regeneration of urothelium, detrusor smooth muscle, and nerve fibers within 3 months post-operatively. In our functional evaluation of bladder strips, we compared hAM-augmented bladders with bladders augmented using small intestinal submucosa (SIS). For example, at 6 months post-operatively, contractions of the following size (as a percentage of the responses in the control-bladder group) were obtained in response to high potassium, carbachol, and electrical field stimulation, respectively: hAM 22% vs SIS 15%, hAM 15% vs SIS 7%, hAM 5.3% vs SIS 1.3% (no significant differences, hAM vs SIS). Both hAM- and SIS-augmented bladders displayed adequate capacity and compliance. The present results indicate that, for bladder augmentation, hAM can be used as a scaffold and is comparable in this respect with SIS. hAM can be more easily obtained than SIS and requires little preparation, and its use raises few ethical questions. Hence, hAM may represent a new therapeutic alternative for urological reconstructions.

Entities:  

Mesh:

Year:  2007        PMID: 17518600     DOI: 10.1089/ten.2006.0170

Source DB:  PubMed          Journal:  Tissue Eng        ISSN: 1076-3279


  11 in total

1.  Recent advances in urologic tissue engineering.

Authors:  Christopher C Roth; Bradley P Kropp
Journal:  Curr Urol Rep       Date:  2009-03       Impact factor: 3.092

2.  Towards a richer debate on tissue engineering: a consideration on the basis of NEST-ethics.

Authors:  A J M Oerlemans; M E C van Hoek; E van Leeuwen; S van der Burg; W J M Dekkers
Journal:  Sci Eng Ethics       Date:  2012-11-15       Impact factor: 3.525

Review 3.  Amniotic membrane in oral and maxillofacial surgery.

Authors:  Marco Rainer Kesting; Klaus-Dietrich Wolff; Christopher Philipp Nobis; Nils Hagen Rohleder
Journal:  Oral Maxillofac Surg       Date:  2012-12-16

4.  The performance of silk scaffolds in a rat model of augmentation cystoplasty.

Authors:  Abhishek Seth; Yeun Goo Chung; Eun Seok Gil; Duong Tu; Debra Franck; Dolores Di Vizio; Rosalyn M Adam; David L Kaplan; Carlos R Estrada; Joshua R Mauney
Journal:  Biomaterials       Date:  2013-03-29       Impact factor: 12.479

5.  Human Amniotic Membrane as a Novel Scaffold for Inducible Pluripotent Stem Cell-derived Kidney Organoids.

Authors:  Maria Figetakis; Kevin J James; Natalia Kosyakova; Richard Torres; William G Chang
Journal:  ASAIO J       Date:  2021-05-06       Impact factor: 3.826

6.  Tetronic(®)-based composite hydrogel scaffolds seeded with rat bladder smooth muscle cells for urinary bladder tissue engineering applications.

Authors:  Srikanth Sivaraman; Rachel Ostendorff; Benjamin Fleishman; Jiro Nagatomi
Journal:  J Biomater Sci Polym Ed       Date:  2014-12-13       Impact factor: 3.517

Review 7.  Silk Fibroin Scaffolds for Urologic Tissue Engineering.

Authors:  Bryan S Sack; Joshua R Mauney; Carlos R Estrada
Journal:  Curr Urol Rep       Date:  2016-02       Impact factor: 3.092

8.  Amniotic fluid and amniotic membrane stem cells: marker discovery.

Authors:  Maria G Roubelakis; Ourania Trohatou; Nicholas P Anagnou
Journal:  Stem Cells Int       Date:  2012-06-03       Impact factor: 5.443

9.  Glutaraldehyde cross-linking of amniotic membranes affects their nanofibrous structures and limbal epithelial cell culture characteristics.

Authors:  Jui-Yang Lai; David Hui-Kang Ma
Journal:  Int J Nanomedicine       Date:  2013-10-31

Review 10.  Amniotic therapeutic biomaterials in urology: current and future applications.

Authors:  Siam Oottamasathien; James M Hotaling; James R Craig; Jeremy B Myers; William O Brant
Journal:  Transl Androl Urol       Date:  2017-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.